STAT+: 厳しい状況に直面するワクチンメーカー、希望の兆しを見出す
原題: STAT+: Facing a brutal run, battered vaccine makers still see cause for hope
分析結果
- カテゴリ
- 医療
- 重要度
- 51
- トレンドスコア
- 12
- 要約
- ワクチンメーカーは、厳しい市場環境や競争に直面しながらも、将来への希望を見出しています。新たなワクチンの開発や、既存のワクチンの改良に取り組むことで、需要の回復を期待しています。また、公共の健康意識の高まりや新たな感染症への対応が、業界の成長を促す要因となる可能性があります。
- キーワード
It's an unusual time to be in the vaccine business. But in the view of those gathered at the BIO conference this week, it’s not altogether a bleak one. It's an unusual time to be in the vaccine business. But in the view of those gathered at the BIO conference this week, it’s not altogether a bleak one. SAN DIEGO — It is an unusual time to be in the vaccine business. But in the view of those gathered here at the BIO international conference this week, it’s not altogether a bleak one. In fact, some vaccine makers are feeling more optimistic than they were a year ago — considering the circumstances, at least. In interviews with STAT, they acknowledged that Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, has brought once-unthinkable disruptions — the cancellation of major mRNA vaccine contracts , the dismantling of universal vaccine recommendations , cuts to government funding for research — and that Washington could deliver more ahead. Continue to STAT+ to read the full story…